Showing results (681-690 of 762) with videos related to

Sort By:
Pageof 77
ESMO Open|August 5, 2025
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trialD Melisi, T Macarulla, C De La Fouchardière, et al.
Scientific Reports|March 27, 2020
In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro diseaseMânlio Tasso de Oliveira Mota, Vivian Vasconcelos Costa, Michelle Amantéa Sugimoto, et al.
Nature Genetics|February 16, 2005
Integrated transcriptional profiling and linkage analysis for identification of genes underlying diseaseNorbert Hubner, Caroline A Wallace, Heike Zimdahl, et al.
The Lancet. Oncology|June 22, 2014
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trialSusan J Dutton, David R Ferry, Jane M Blazeby, et al.
Lancet (London, England)|September 14, 2023
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trialZev A Wainberg, Davide Melisi, Teresa Macarulla, et al.
Frontiers in Endocrinology|June 24, 2021
The Impact of <sup>68</sup>Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine TumoursDaniel J Cuthbertson, Jorge Barriuso, Angela Lamarca, et al.
Cell Stem Cell|April 7, 2009
A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identityLi Ding, Maciej Paszkowski-Rogacz, Anja Nitzsche, et al.
Molecular Cell|September 23, 2022
SAMHD1 controls innate immunity by regulating condensation of immunogenic self RNAShovamayee Maharana, Stefanie Kretschmer, Susan Hunger, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2018
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trialLi-Tzong Chen, Jens T Siveke, Andrea Wang-Gillam, et al.
Teaching and Learning in Medicine|April 13, 2026
Contemporary Step 1 Predictive Methods Across 12 US MD-Granting Medical SchoolsChristian C Steciuch, James H Baños, Todd A Bates, et al.
Pageof 77